Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Hansen

Showing results (101-110 of 103) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 103 results.
American Journal of Medical Genetics. Part A|July 14, 2006
Clinical dividends from the molecular genetic diagnosis of craniosynostosisAndrew O M Wilkie, Elena G Bochukova, Ruth M S Hansen, et al.
American Journal of Medical Genetics. Part A|July 11, 2007
Clinical dividends from the molecular genetic diagnosis of craniosynostosisAndrew O M Wilkie, Elena G Bochukova, Ruth M S Hansen, et al.
Annals of the Rheumatic Diseases|May 11, 2013
Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trialT W Jensen, M S Hansen, K Hørslev-Petersen, et al.
Pageof 11

Showing results (101-110 of 103) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 103 results.
American Journal of Medical Genetics. Part A|July 14, 2006
Clinical dividends from the molecular genetic diagnosis of craniosynostosisAndrew O M Wilkie, Elena G Bochukova, Ruth M S Hansen, et al.
American Journal of Medical Genetics. Part A|July 11, 2007
Clinical dividends from the molecular genetic diagnosis of craniosynostosisAndrew O M Wilkie, Elena G Bochukova, Ruth M S Hansen, et al.
Annals of the Rheumatic Diseases|May 11, 2013
Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trialT W Jensen, M S Hansen, K Hørslev-Petersen, et al.
Pageof 11